Company data
Ionis Pharmaceuticals, Inc. employees and revenue per employee
IONS · Biotechnology · $4.43B market cap
Ionis Pharmaceuticals, Inc. had 1,402 employees at the end of fiscal Dec 2025, up 31.2% from a year earlier. Revenue for the year was $944M, up 33.9% from a year earlier, or $673K per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
1,402
+31.2% YoY
Revenue
$944M
+33.9% YoY
Revenue / employee
$673K
Peer median $457K
Rank in industry
44 of 110
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 1,402 | $944M | $673K | +31.2% | +33.9% |
| Dec 2024 | 1,069 | $705M | $660K | +15.3% | -10.5% |
| Dec 2023 | 927 | $788M | $850K | +16.5% | +34.1% |
| Dec 2022 | 796 | $587M | $738K | +20.6% | -27.5% |
| Dec 2021 | 660 | $810M | $1.23M | -12.8% | +11.1% |
| Dec 2020 | 757 | $729M | $963K | -7.3% | -35.0% |
| Dec 2019 | 817 | $1.12B | $1.37M | +10.9% | +87.2% |
| Dec 2018 | 737 | $600M | $814K | +34.7% | +16.6% |
| Dec 2017 | 547 | $514M | $940K | +25.7% | +37.9% |
| Dec 2016 | 435 | $373M | $857K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Ionis Pharmaceuticals, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings, Inc. | 293 | $868M | $2.96M | Efficient growth |
| BCRX BioCryst Pharmaceuticals, Inc. | 435 | $875M | $2.01M | Leaner |
| NVAX Novavax, Inc. | 749 | $1.12B | $1.50M | Leaner |
| ACAD Acadia Pharmaceuticals Inc. | 653 | $958M | $1.47M | Efficient growth |
| ARWR Arrowhead Pharmaceuticals, Inc. | 711 | $829M | $1.17M | Efficient growth |
| MDGL Madrigal Pharmaceuticals, Inc. | 915 | $958M | $1.05M | Efficient growth |
| IONS Ionis Pharmaceuticals, Inc. | 1,402 | $944M | $673K | Efficient growth |
| TECH Bio-Techne Corporation | 3,000 | $1.22B | $405K | Contracting |
| LEGN Legend Biotech Corporation | 2,900 | $1.03B | $355K | Efficient growth |
Questions about Ionis Pharmaceuticals, Inc.
- How many employees does Ionis Pharmaceuticals, Inc. have?
- Ionis Pharmaceuticals, Inc. reported 1,402 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is up 31.2% from a year earlier.
- What is Ionis Pharmaceuticals, Inc.'s revenue per employee?
- Ionis Pharmaceuticals, Inc. brought in $944M of revenue in fiscal Dec 2025, which is $673K per employee. That ranks 44 of 110 companies we track in Biotechnology, where the median is $457K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Outpick research
This page is the filings. The research is a membership.
On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare IONS with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Ionis Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed February 26, 2026. This is data, not a recommendation to buy or sell IONS.